Gestational Trophoblastic Tumours

  • Rajeev ShahEmail author
  • Aaron Ervine


Gestational Trophoblastic Tumours: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM8/FIGO are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the more common non-carcinoma malignancies that are encountered at this site in diagnostic practice.


Molar pregnancy Complete hydatidiform mole Partial hydatidiform mole Choriocarcinoma Invasive hydatidiform mole Placental site trophoblastic tumour Epithelioid trophoblastic tumour FIGO 


  1. Baergen N. Manual of pathology of the human placenta. 2nd ed. Berlin: Springer; 2011.CrossRefGoogle Scholar
  2. Fox H, Wells M, editors. Haines and Taylor. Obstetrical and gynaecological pathology. 5th ed. London: Churchill Livingstone; 2003.Google Scholar
  3. Fox H, Sebire N. Pathology of the placenta, Major problems in pathology series 7. 3rd ed. Philadelphia: Saunders; 2007.Google Scholar
  4. Kaplan CG. Color atlas of gross placental pathology. 2nd ed. Berlin: Springer; 2006.Google Scholar
  5. Lage JM. Protocol for the examination of specimens from patients with gestational trophoblastic malignancies. Arch Pathol Lab Med. 1999;123:50–4.PubMedGoogle Scholar
  6. Lage JM, Minamiguchi S, Richardson MS. Gestational trophoblastic diseases: update on new immunohistochemical findings. Curr Diagn Pathol. 2003;9:1–10.CrossRefGoogle Scholar
  7. Paradinas FJ. The histological diagnosis of hydatidiform moles. Curr Diagn Pathol. 1994;1:24–31.CrossRefGoogle Scholar
  8. Paradinas FJ. The differential diagnosis of choriocarcinoma and placental site tumour. Curr Diagn Pathol. 1998;5:93–101.CrossRefGoogle Scholar
  9. Robboy SJ, Bentley RC, Russell R, Anderson MC, Mutter GL, Prat J. Pathology of the female reproductive tract. 2nd ed. London: Churchill Livingstone Elsevier; 2009.Google Scholar
  10. Sebire NJ, Rees H. Diagnosis of gestational trophoblastic disease in early pregnancy. Curr Diagn Pathol. 2002;8:430–40.CrossRefGoogle Scholar
  11. Sebire NJ, Rees HC, Peston D, Seckl MJ, Newlands ES, Fisher RA. P57 KIP2 immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy. Histopathology. 2004;45:135–41.CrossRefGoogle Scholar
  12. Silverberg SG, Kurman RJ. Tumors of the uterine corpus and gestational trophoblastic disease, Atlas of tumor pathology, vol. 3. Washington, DC: AFIP; 1992.Google Scholar
  13. The Royal College of Pathologists. Tissue pathway for histopathological examination of the placenta. 2015.

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Cellular PathologyCraigavon Area HospitalCraigavonUK

Personalised recommendations